Remote Medical Strategy Associate Director, Prostate Cancer

Sumitomo Pharma

Frankfort (KY)

Remote

USD 191,000 - 239,000

Full time

11 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Sumitomo Pharma America (SMPA) is seeking an Associate Director, Medical Strategy (Prostate Cancer) to lead medical strategy, scientific communications, and publication planning for prostate cancer programs. This role reports to the Medical Affairs Director, Solid Tumors and partners with cross-functional teams to drive external engagement and strategic plans.

Primarily remote with up-to 25% travel; a PharmD/PhD/MD/DO or equivalent advanced degree and 8+ years' Medical Affairs or related life

Qualifications

Advanced degree required; PharmD, PhD, MD, DO, or equivalent strongly preferred.
Minimum of 8 years of relevant experience in the pharmaceutical, biotechnology, healthcare, or related life sciences industry.
Medical Affairs experience preferred; oncology experience required.
Experience supporting medical strategy, scientific communications, publication planning, evidence generation, or field medical collaboration preferred.
Experience working with cross-functional teams and external scientific experts in a compliant, highly regulated environment preferred.

Responsibilities

Serves as the medical director for assigned prostate cancer projects, providing medical and scientific leadership in collaboration with the Medical Affairs Director, Solid Tumors TA Lead.
Collaborates with the Medical Affairs Director to develop Medical Affairs strategic plans aligned with brand imperatives and informed by external engagement, input, and insights.
Supports coordination and alignment of Medical Affairs activities with external alliance partners for assigned projects.
Provides medical input into the development and execution of Medical Affairs plans and scientific platforms.
Partners with U.S. Field Medical, Medical Communications & Operations, RWE & HEOR, and ex-U.S. colleagues to support cross-functional medical alignment.